Journal of Medical Economics, Volume 23, Issue 9 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 23, Issue 9 (2020)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Volume 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Pharmacoeconomic Trends

Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics
Roger Lee Mendoza
Pages: 915-922
Published online: 25 Jun 2020
AbstractforEffects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics | Full Text | References | PDF (633.6 KB) | EPUB
  • 4838 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Editorial
Biomarkers and pharmacoeconomics in rheumatoid arthritis: a good marriage
Maurizio Benucci, Maria Infantino & Mariangela Manfredi
Pages: 923-925
Published online: 21 May 2020
First Page PreviewforBiomarkers and pharmacoeconomics in rheumatoid arthritis: a good marriage | Full Text | References | PDF (262.5 KB) | EPUB
  • 1315 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Women's Health

Article
Preeclampsia in Switzerland: a cost analysis in two hospitals
Markus Hodel, Patricia R. Blank, Petra Marty & Olav Lapaire
Pages: 926-931
Published online: 18 Jun 2020
AbstractforPreeclampsia in Switzerland: a cost analysis in two hospitals | Full Text | References | PDF (985.9 KB) | EPUB
  • 1722 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Health Financing

Review Article
Analysis of the economic situation of the South East European pharmaceutical industry
Jovana Milenković & Dragana Lakić
Pages: 932-939
Published online: 20 May 2020
AbstractforAnalysis of the economic situation of the South East European pharmaceutical industry | Full Text | References | PDF (637.3 KB) | EPUB
  • 864 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Subscriber continuity in health insurance plans: factors associated with re-enrollment and coverage changes
Melissa H. Roberts, Xuanhao He, Claudia Díaz Fuentes & Nicholas Edwardson
Pages: 940-951
Published online: 02 Jul 2020
AbstractforSubscriber continuity in health insurance plans: factors associated with re-enrollment and coverage changes | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 871 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Cost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer
Mohamed Ismail Abdul Aziz, Ling Eng Tan, Wan Hui Gloria Tan, Chee-Keong Toh, Lydia Pui Yee Loke, Fiona Pearce & Kwong Ng
Pages: 952-960
Published online: 22 Jun 2020
AbstractforCost-effectiveness analysis of pembrolizumab monotherapy versus chemotherapy for previously untreated advanced non-small cell lung cancer | Full Text | References | PDF (1.8 MB) | EPUB | Supplemental
  • 3884 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Article
Analysis of treatment cost for neuroblastoma to the family: a single-center cross-sectional study in China
Chiyi Jiang, Siyu Cai, Chao Duan, Na Xu, Yuchen Zhou, Xiaoxia Peng & Xiaoli Ma
Pages: 961-966
Published online: 07 Jul 2020
AbstractforAnalysis of treatment cost for neuroblastoma to the family: a single-center cross-sectional study in China | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2614 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
The cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States
Rachael Louise Slater, Yizhen Lai, Yichen Zhong, Haojie Li, Yang Meng, Blanca Homet Moreno, James Luke Godwin, Tara Frenkl, Guru P. Sonpavde & Ronac Mamtani
Pages: 967-977
Published online: 12 Jun 2020
AbstractforThe cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 2625 Views
  • 12 CrossRef citations
  • 0Altmetric
Free Access

Genetic Disease

Article
Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS)
Louis S. Matza, Glenn A. Phillips, Timothy A. Howell, Nicole Ciffone & Zahid Ahmad
Pages: 978-984
Published online: 01 Jul 2020
AbstractforEstimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS) | Full Text | References | PDF (668.9 KB) | EPUB | Supplemental
  • 2040 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

Diabetes

Article
Cost of macrovascular complications in people with diabetes from a public healthcare perspective: a retrospective database study in Brazil
Guilherme Silva Julian, Daniel Campos, Julie Broe Honore, Flávia Sauer Tobaruella, Jung Hyun Yoon & Nino Hallén
Pages: 985-993
Published online: 20 May 2020
AbstractforCost of macrovascular complications in people with diabetes from a public healthcare perspective: a retrospective database study in Brazil | Full Text | References | PDF (1,018.2 KB) | EPUB | Supplemental
  • 2084 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

Urology

Article
Assessing the burden of nocturia in the workplace: the associations between nocturnal voiding, subjective well-being, work engagement and productivity
Marco Hafner, Fredrik L. Andersson, Teodor Burtea, Christian van Stolk, Michael Whitmore, Erez Yerushalmi & Wendy M. Troxel
Pages: 994-1003
Published online: 02 Jun 2020
AbstractforAssessing the burden of nocturia in the workplace: the associations between nocturnal voiding, subjective well-being, work engagement and productivity | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 1587 Views
  • 10 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic analysis of Electrical Muscle Stimulator with Multipath technology for the treatment of stress urinary incontinence: a UK-based cost-utility analysis
Mehdi Javanbakht, Atefeh Mashayekhi, Ash Monga, Jowan Atkinson & Michael Branagan-Harris
Pages: 1004-1015
Published online: 18 Jun 2020
AbstractforEconomic analysis of Electrical Muscle Stimulator with Multipath technology for the treatment of stress urinary incontinence: a UK-based cost-utility analysis | Full Text | References | PDF (2.2 MB) | EPUB
  • 1161 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Hematology

Article
Estimation of total costs in patients with relapsed or refractory diffuse large B-cell lymphoma receiving tisagenlecleucel from a US hospital’s perspective
Hongbo Yang, Yanni Hao, Xinglei Chai, Cynthia Z. Qi & Eric Q. Wu
Pages: 1016-1024
Published online: 02 Jun 2020
AbstractforEstimation of total costs in patients with relapsed or refractory diffuse large B-cell lymphoma receiving tisagenlecleucel from a US hospital’s perspective | Full Text | References | PDF (895.5 KB) | EPUB | Supplemental
  • 2525 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

Rheumatology

Article
Comparison of infection-related hospitalization risk and costs in tumor necrosis factor inhibitor-experienced patients with rheumatoid arthritis (RA) treated with abatacept or other targeted disease-modifying anti-rheumatic drugs (tDMARDs)
Damemarie Paul, Dhaval Patil, Laura McDonald, Vardhaman Patel & Francis Lobo
Pages: 1025-1031
Published online: 13 Jun 2020
AbstractforComparison of infection-related hospitalization risk and costs in tumor necrosis factor inhibitor-experienced patients with rheumatoid arthritis (RA) treated with abatacept or other targeted disease-modifying anti-rheumatic drugs (tDMARDs) | Full Text | References | PDF (825.7 KB) | EPUB | Supplemental
  • 1351 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Mental Health

Article
Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States
Eric Armbrecht, Anuj Shah, Patricia Schepman, Ruchit Shah, Elizabeth Pappadopulos, Richard Chambers, Jennifer Stephens, Seema Haider & Roger S. McIntyre
Pages: 1032-1042
Published online: 25 Jun 2020
AbstractforEconomic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States | Full Text | References | PDF (2.1 MB) | EPUB
  • 2491 Views
  • 18 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles